Ifosfamide: should the honeymoon be over?
Kamen
B A
BA
Frenkel
E
E
Colvin
O M
OM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000633:toxicity; D002490:Central Nervous System / Q000187:drug effects; D002648:Child; D002945:Cisplatin / Q000633:toxicity; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism / Q000633:toxicity; D004334:Drug Administration Schedule; D004361:Drug Tolerance; D005047:Etoposide / Q000633:toxicity; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects; D009447:Neuroblastoma / Q000188:drug therapy; D013997:Time Factors
C012358:4-hydroxycyclophosphamide; D005047:Etoposide; D003520:Cyclophosphamide; D002945:Cisplatin; D007069:Ifosfamide